you are here: Home News Warning Letter

Warning Letter

Indoco Remedies shares fall after USFDA warning letter over Goa facility
Sebi sent 377 warnings to AIFs in FY24 against 20 in the previous year
USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant
Committed to maintain highest quality, FDA warning letter on Bardez plant won’t impact supplies: Glenmark
Lupin: Somerset warning implies regulatory environment may no longer offer relief
Divis Vizag unit fails USFDA audit on alleged reluctance to share drug testing data
US FDA asks Indoco Remedies to hire consultant, review manufacturing ops
Dr Reddy's gains over 4% on buzz Srikakulam API plant cleared US FDA audit
Impact of FDA warning letter on sales minimal, to reply in 15 days: Indoco Remedies
Indoco Remedies at 1-year low on USFDA warning letter for Goa facility
Indoco Remedies gets USFDA warning letter for its Goa facility
Repeat observations on Vizag site spell bad news for Dr.Reddy's
USFDA asks Wockhardt to assess quality systems across its plants
Dr Reddy's gears up for key USFDA audits in next 2 months: Srcs
5 important things about USFDA warning letters, slow resolution
Wockhardt tanks 7% on FDA‘s warning letter to US arm
Sensex, Nifty could see a strong start; Wockhardt in focus
Analysts give a thumbs-up to Cadila on resolution of FDA warning
Cadila gains on resolution of its Moraiya plant warning letter
USFDA to re-audit three Dr Reddy's plants
German regulator clears Wockhardt's Ankleshwar plant
Addressing concern raised by USFDA on Ankleshwar unit: Wockhardt
Sun Pharma up 3%; details of warning letter not worrisome
Sun Pharma gets warning letter from USFDA over Halol unit
Dr Reddy's Labs: The bull vs bear case

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Warning Letter

Indoco Remedies shares fall after USFDA warning letter over Goa facility

Sebi sent 377 warnings to AIFs in FY24 against 20 in the previous year

USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant

Committed to maintain highest quality, FDA warning letter on Bardez plant won’t impact supplies: Glenmark

Lupin: Somerset warning implies regulatory environment may no longer offer relief

Divis Vizag unit fails USFDA audit on alleged reluctance to share drug testing data

US FDA asks Indoco Remedies to hire consultant, review manufacturing ops

Dr Reddy's gains over 4% on buzz Srikakulam API plant cleared US FDA audit

Impact of FDA warning letter on sales minimal, to reply in 15 days: Indoco Remedies

Indoco Remedies at 1-year low on USFDA warning letter for Goa facility

Indoco Remedies gets USFDA warning letter for its Goa facility

Repeat observations on Vizag site spell bad news for Dr.Reddy's

USFDA asks Wockhardt to assess quality systems across its plants

Dr Reddy's gears up for key USFDA audits in next 2 months: Srcs

5 important things about USFDA warning letters, slow resolution

Wockhardt tanks 7% on FDA‘s warning letter to US arm

Sensex, Nifty could see a strong start; Wockhardt in focus

Analysts give a thumbs-up to Cadila on resolution of FDA warning

Cadila gains on resolution of its Moraiya plant warning letter

USFDA to re-audit three Dr Reddy's plants

German regulator clears Wockhardt's Ankleshwar plant

Addressing concern raised by USFDA on Ankleshwar unit: Wockhardt

Sun Pharma up 3%; details of warning letter not worrisome

Sun Pharma gets warning letter from USFDA over Halol unit

Dr Reddy's Labs: The bull vs bear case